Aethlon medical announces $12.425 million registered direct offering priced at-the-market under nasdaq rules

San diego, june 10, 2021 /prnewswire/ -- aethlon medical, inc. (nasdaq:aemd), a medical device technology company focused on unmet needs in global health, today announced that it has entered into a definitive agreement with a single institutional investor for the purchase in a registered direct offering of 1,380,555 shares of its common stock, at a purchase price per share of $9.00, priced at-the-market under nasdaq rules.  the closing of the offering is expected to occur on or about june 14, 2021, subject to the satisfaction of customary closing conditions.
AEMD Ratings Summary
AEMD Quant Ranking